Current management and future directions in the treatment of advanced renal cell carcinoma–a latin american perspective: 10 years in review

Por Smaletz, Oren
Publicado no Int Braz J Urol (2015)

Castration-resistant prostate cancer: systemic therapy in 2012

Por Maluf, Fernando C., Smaletz, Oren, Herchenhorn, Daniel
Publicado em 2012

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics

Por Smaletz, Oren, Chacón, Matias, de Oliveira Koch, Ludmila, de Carvalho Rocha, Daniela R, Cardoso, Fernanda C
Publicado no Onco Targets Ther (2016)

The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011

Por Bognar, Cinthia Leite Frizzera Borges, Simon, Sergio Daniel, Gansl, Rene Claudio, Abramoff, Roberto, Aisen, Marcelo, Lopes, Gilberto de Lima, Smaletz, Oren, Peres, Stela Verzinhasse, Tabacof, Jacques
Publicado no Einstein (Sao Paulo) (2015)

Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered

Por Usón, Pedro Luiz Serrano, França, Monique Sedlmaier, Rodrigues, Heloisa Veasey, Macedo, Antônio Luiz de Vasconcellos, Goldenberg, Alberto, Smaletz, Oren, Armentano, Daniela Pezzutti Domingues, Simon, Sergio Daniel, Gansl, Rene Claudio
Publicado no Einstein (Sao Paulo) (2015)